Pelthos Therapeutics Inc. has appointed Andrew J. Einhorn, a veteran finance executive, to its Board of Directors. Mr. Einhorn will also serve on the Audit Committee and the Compensation Committee. With over four decades of experience in investment banking and C-level finance roles at life science companies, Mr. Einhorn brings valuable expertise to Pelthos. He currently serves as a consultant at Danforth Advisors and has held CFO positions at multiple biotechnology companies. Mr. Einhorn expressed excitement about joining the Pelthos Board and looks forward to contributing to the company’s growth and mission.

Read more at GlobeNewswire: Pelthos Therapeutics Expands Board of Directors with the